Aileron Therapeutics announced that Vojislav (Vojo) Vukovic, MD, PhD, has been named Chief Medical Officer (CMO). He succeeds Manuel Aivado, MD, PhD, who was promoted to Chief Executive Officer on September 6, 2018. In addition, the Company announced the promotion of Allen Annis, PhD, to Senior Vice President of Research. Most recently, Dr. Vukovic was the CMO of Taiho Oncology, where he oversaw the reorganization and scaling of the U.S. and European R&D function to advance the development of the company's clinical programs.